Showing results (131-140 of 216) with videos related to
Sort By:
Pageof 22
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2019
Comprehensive Genomic Profiling Identifies Novel Genetic Predictors of Response to Anti-PD-(L)1 Therapies in Non-Small Cell Lung CancerWenfeng Fang, Yuxiang Ma, Jiani C Yin, et al.Annals of Translational Medicine|November 9, 2019
Multi-targeted tyrosine kinase inhibitors as third-line regimen in advanced non-small cell lung cancer: a network meta-analysisZhonghan Zhang, Yuanyuan Zhao, Feiteng Lu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2022
FOXM1 Variant Contributes to Gefitinib Resistance via Activating Wnt/β-Catenin Signal Pathway in Patients with Non-Small Cell Lung CancerShaoxing Guan, Xi Chen, Youhao Chen, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 8, 2018
First-in-Human Phase I Study of AC0010, a Mutant-Selective EGFR Inhibitor in Non-Small Cell Lung Cancer: Safety, Efficacy, and Potential Mechanism of ResistanceYuxiang Ma, Xin Zheng, Hongyun Zhao, et al.Annals of Translational Medicine|September 3, 2019
Impact of prior cancer on outcomes in nasopharyngeal carcinomaHuaqiang Zhou, Yaxiong Zhang, Jiaqing Liu, et al.Therapeutic Advances in Medical Oncology|January 8, 2020
Pemetrexed/carboplatin plus gefitinib as a first-line treatment for EGFR-mutant advanced nonsmall cell lung cancer: a Bayesian network meta-analysisZhonghan Zhang, Kangmei Zeng, Shen Zhao, et al.Future Oncology (London, England)|June 27, 2019
Cause-specific death assessment of patients with stage I small-cell lung cancer: a competing risk analysisJiaqing Liu, Huaqiang Zhou, Yaxiong Zhang, et al.Journal of Hematology & Oncology|July 27, 2025
Iparomlimab and tuvonralimab (QL1706) plus chemotherapy and bevacizumab for EGFR-mutant patients with advanced non-small cell lung cancer after failure of EGFR-tyrosine kinase inhibitors: updated results from cohort 5 in the DUBHE-L-201 studyYaxiong Zhang, Yan Huang, Yunpeng Yang, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 21, 2014
The prognostic nutritional index (PNI) predicts overall survival of small-cell lung cancer patientsShaodong Hong, Ting Zhou, Wenfeng Fang, et al.ESMO Open|February 15, 2020
Impact of prior cancer history on the overall survival of younger patients with lung cancerJiaqing Liu, Huaqiang Zhou, Yaxiong Zhang, et al.Pageof 22